We are proud to announce that the consortium Acellmed – Silesian Park of Medical Technology – University of Wroclaw received funding in “The Competition for the development of innovative therapeutic solutions using RNA technology” (ABM/2021/5), organized by the Medical Research Agency

Our project, entitled “Mutation-resistant nanotherapeutics inhibiting infection progress of RNA-virus, SARS-CoV-2” received the highest score among all submissions.

For more information, please check out here.